Pamela Stuart Jones, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pituitary Neoplasms | 9 | 2024 | 1354 | 1.520 |
Why?
|
Adenoma | 5 | 2022 | 2182 | 0.980 |
Why?
|
Pituitary ACTH Hypersecretion | 2 | 2024 | 176 | 0.910 |
Why?
|
Glioma | 5 | 2021 | 3423 | 0.760 |
Why?
|
Skull Base Neoplasms | 2 | 2014 | 288 | 0.730 |
Why?
|
Levulinic Acids | 1 | 2019 | 16 | 0.710 |
Why?
|
Protoporphyrins | 1 | 2019 | 162 | 0.680 |
Why?
|
Monitoring, Intraoperative | 2 | 2021 | 952 | 0.550 |
Why?
|
Craniopharyngioma | 4 | 2021 | 284 | 0.540 |
Why?
|
Photosensitizing Agents | 1 | 2019 | 599 | 0.510 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2019 | 883 | 0.440 |
Why?
|
Brain Neoplasms | 6 | 2021 | 8947 | 0.420 |
Why?
|
Chondrosarcoma | 1 | 2014 | 308 | 0.400 |
Why?
|
Fluorescent Dyes | 1 | 2019 | 1919 | 0.400 |
Why?
|
Chordoma | 1 | 2014 | 356 | 0.380 |
Why?
|
Pathology, Molecular | 1 | 2013 | 331 | 0.350 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2019 | 2042 | 0.230 |
Why?
|
Microelectrodes | 2 | 2021 | 304 | 0.230 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2021 | 9305 | 0.220 |
Why?
|
Evoked Potentials, Somatosensory | 2 | 2021 | 248 | 0.210 |
Why?
|
Mutation | 7 | 2021 | 29981 | 0.210 |
Why?
|
Adrenal Insufficiency | 1 | 2024 | 185 | 0.200 |
Why?
|
Tumor Escape | 2 | 2021 | 351 | 0.200 |
Why?
|
Craniotomy | 3 | 2021 | 737 | 0.200 |
Why?
|
Meningeal Carcinomatosis | 1 | 2021 | 65 | 0.190 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2021 | 82 | 0.190 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2022 | 647 | 0.180 |
Why?
|
Pituitary Diseases | 1 | 2021 | 141 | 0.170 |
Why?
|
Aminolevulinic Acid | 1 | 2019 | 137 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 7 | 2022 | 35798 | 0.160 |
Why?
|
Tumor Burden | 2 | 2014 | 1917 | 0.160 |
Why?
|
Evoked Potentials, Motor | 1 | 2021 | 452 | 0.150 |
Why?
|
Acromegaly | 1 | 2020 | 348 | 0.140 |
Why?
|
Neoplasm, Residual | 2 | 2019 | 984 | 0.140 |
Why?
|
Brain Mapping | 3 | 2021 | 6647 | 0.140 |
Why?
|
Telomerase | 1 | 2020 | 734 | 0.130 |
Why?
|
Frontal Lobe | 1 | 2022 | 1398 | 0.130 |
Why?
|
Thalamus | 1 | 2021 | 1032 | 0.120 |
Why?
|
Accidental Falls | 1 | 2022 | 1066 | 0.120 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1389 | 0.120 |
Why?
|
Motor Cortex | 1 | 2021 | 993 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6542 | 0.110 |
Why?
|
Central Nervous System Neoplasms | 1 | 2021 | 898 | 0.110 |
Why?
|
Treatment Outcome | 6 | 2022 | 64017 | 0.110 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2016 | 901 | 0.100 |
Why?
|
Reoperation | 1 | 2022 | 4248 | 0.100 |
Why?
|
Meningeal Neoplasms | 1 | 2021 | 1249 | 0.100 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2020 | 2002 | 0.100 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2022 | 1395 | 0.100 |
Why?
|
Intraoperative Complications | 1 | 2019 | 1206 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2183 | 0.100 |
Why?
|
Middle Aged | 15 | 2021 | 216054 | 0.100 |
Why?
|
Adult | 16 | 2021 | 216658 | 0.100 |
Why?
|
Surgery, Computer-Assisted | 1 | 2019 | 1024 | 0.100 |
Why?
|
Fourth Ventricle | 1 | 2011 | 30 | 0.100 |
Why?
|
Molecular Targeted Therapy | 3 | 2019 | 2755 | 0.100 |
Why?
|
Aged | 11 | 2022 | 165629 | 0.090 |
Why?
|
Humans | 29 | 2024 | 752741 | 0.090 |
Why?
|
Neurocysticercosis | 1 | 2011 | 62 | 0.090 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12250 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2021 | 11626 | 0.090 |
Why?
|
Cell Survival | 1 | 2019 | 5860 | 0.090 |
Why?
|
Electroencephalography | 2 | 2021 | 6117 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3700 | 0.080 |
Why?
|
Epilepsy | 2 | 2021 | 3319 | 0.080 |
Why?
|
Databases, Factual | 2 | 2014 | 7805 | 0.080 |
Why?
|
Cell Line, Tumor | 3 | 2020 | 16789 | 0.080 |
Why?
|
Ion Transport | 1 | 2009 | 319 | 0.080 |
Why?
|
Male | 16 | 2021 | 354311 | 0.080 |
Why?
|
Cancer Vaccines | 1 | 2016 | 1041 | 0.080 |
Why?
|
Female | 17 | 2022 | 385090 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8660 | 0.080 |
Why?
|
Inpatients | 1 | 2019 | 2549 | 0.080 |
Why?
|
Age Factors | 2 | 2014 | 18460 | 0.070 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9743 | 0.070 |
Why?
|
Odds Ratio | 1 | 2019 | 9863 | 0.070 |
Why?
|
Seizures | 1 | 2019 | 2887 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 2 | 2019 | 5584 | 0.060 |
Why?
|
Brain | 3 | 2022 | 26598 | 0.060 |
Why?
|
Electric Stimulation | 2 | 2021 | 1756 | 0.060 |
Why?
|
Cerebral Cortex | 1 | 2021 | 5725 | 0.060 |
Why?
|
Brain Edema | 1 | 2009 | 614 | 0.060 |
Why?
|
Hydrocephalus | 1 | 2011 | 761 | 0.060 |
Why?
|
Young Adult | 5 | 2021 | 57267 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18174 | 0.060 |
Why?
|
Internship and Residency | 1 | 2023 | 5858 | 0.060 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10256 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2016 | 4403 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2016 | 4549 | 0.050 |
Why?
|
Infant | 2 | 2014 | 35447 | 0.050 |
Why?
|
Neurons | 1 | 2021 | 9439 | 0.050 |
Why?
|
Wavelet Analysis | 1 | 2021 | 57 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2021 | 58361 | 0.050 |
Why?
|
Child, Preschool | 2 | 2014 | 41390 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2024 | 78758 | 0.050 |
Why?
|
Anorexia | 1 | 2021 | 162 | 0.050 |
Why?
|
Mice, Inbred ICR | 1 | 2021 | 356 | 0.050 |
Why?
|
Glioblastoma | 1 | 2016 | 3494 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2021 | 5144 | 0.050 |
Why?
|
Sex Factors | 1 | 2014 | 10469 | 0.040 |
Why?
|
Hepatitis | 1 | 2021 | 226 | 0.040 |
Why?
|
Electrophysiological Phenomena | 1 | 2021 | 315 | 0.040 |
Why?
|
Extracellular Space | 1 | 2021 | 596 | 0.040 |
Why?
|
United States | 3 | 2023 | 70772 | 0.040 |
Why?
|
Mice | 3 | 2021 | 81766 | 0.040 |
Why?
|
Nausea | 1 | 2021 | 675 | 0.040 |
Why?
|
Optical Phenomena | 1 | 2019 | 106 | 0.040 |
Why?
|
Adolescent | 3 | 2019 | 86713 | 0.040 |
Why?
|
Pituitary Gland | 1 | 2021 | 667 | 0.040 |
Why?
|
Prognosis | 2 | 2021 | 29264 | 0.040 |
Why?
|
Lectins, C-Type | 1 | 2021 | 601 | 0.040 |
Why?
|
Somatosensory Cortex | 1 | 2021 | 530 | 0.040 |
Why?
|
Exanthema | 1 | 2021 | 506 | 0.040 |
Why?
|
Acoustic Stimulation | 1 | 2021 | 1228 | 0.040 |
Why?
|
4-1BB Ligand | 1 | 2016 | 29 | 0.030 |
Why?
|
OX40 Ligand | 1 | 2016 | 51 | 0.030 |
Why?
|
Hydrocortisone | 1 | 2024 | 1824 | 0.030 |
Why?
|
Child | 2 | 2014 | 78594 | 0.030 |
Why?
|
Brain Ischemia | 1 | 2009 | 3284 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1074 | 0.030 |
Why?
|
Animals | 4 | 2021 | 169600 | 0.030 |
Why?
|
Postoperative Period | 1 | 2020 | 1848 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2021 | 2389 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14761 | 0.030 |
Why?
|
Fatigue | 1 | 2021 | 1536 | 0.030 |
Why?
|
K562 Cells | 1 | 2016 | 641 | 0.030 |
Why?
|
Oximes | 1 | 2015 | 309 | 0.030 |
Why?
|
Fever | 1 | 2021 | 1627 | 0.030 |
Why?
|
Valine | 1 | 2015 | 411 | 0.030 |
Why?
|
Colitis | 1 | 2021 | 1196 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2015 | 383 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2021 | 2002 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2021 | 1834 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2022 | 2457 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2071 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2021 | 2161 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4179 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2881 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2023 | 2322 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2020 | 6169 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2016 | 2125 | 0.020 |
Why?
|
Pyridones | 1 | 2015 | 738 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2228 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2015 | 1164 | 0.020 |
Why?
|
Biopsy | 1 | 2022 | 6771 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 21976 | 0.020 |
Why?
|
Cohort Studies | 2 | 2024 | 40939 | 0.020 |
Why?
|
Sodium-Potassium-Chloride Symporters | 1 | 2009 | 102 | 0.020 |
Why?
|
Imidazoles | 1 | 2015 | 1201 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2020 | 5858 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10252 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2775 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2009 | 590 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4943 | 0.020 |
Why?
|
Nanoparticles | 1 | 2019 | 1944 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4232 | 0.020 |
Why?
|
Endothelium | 1 | 2009 | 779 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2022 | 13042 | 0.020 |
Why?
|
Length of Stay | 1 | 2019 | 6355 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 5552 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9431 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2021 | 21904 | 0.010 |
Why?
|
Vaccination | 1 | 2016 | 3354 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22009 | 0.010 |
Why?
|
Blood-Brain Barrier | 1 | 2009 | 1017 | 0.010 |
Why?
|
Models, Biological | 1 | 2019 | 9569 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 25454 | 0.010 |
Why?
|
Depression | 1 | 2022 | 7876 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 12821 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39223 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 13984 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40195 | 0.010 |
Why?
|
Risk Factors | 1 | 2019 | 73094 | 0.010 |
Why?
|